Biotest AG
XETRA:BIO0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
XETRA:BIO0
|
DE |
|
Quantum Graphite Ltd
ASX:QGL
|
AU |
|
Samudera Indonesia Tbk PT
IDX:SMDR
|
ID |
|
E
|
Encounter Resources Ltd
ASX:ENR
|
AU |
|
AssetMark Financial Holdings Inc
F:0LA
|
US |
|
H
|
Helium Evolution Inc
OTC:HEEVF
|
CA |
|
T
|
Transat AT Inc
OTC:TRZBF
|
CA |
|
H
|
Helium Evolution Inc
XTSX:HEVI
|
CA |
|
J
|
Juggernaut Exploration Ltd
OTC:JUGRF
|
CA |
|
R
|
Rane (Madras) Ltd
NSE:RML
|
IN |
|
Bionomics Ltd
F:B1N
|
AU |
|
A
|
Atalaya Mining PLC
LSE:ATYM
|
CY |
|
Belimo Holding AG
SIX:BEAN
|
CH |
|
Daktronics Inc
NASDAQ:DAKT
|
US |
|
Capcom Co Ltd
OTC:CCOEF
|
JP |
|
N
|
NioCorp Developments Ltd
XBER:BR3
|
US |
|
W
|
WH Group Ltd
SWB:0WH
|
HK |
|
P
|
Poly Medicure Ltd
BSE:531768
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIO0's stock price target?
Not Available
BIO0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.